Epoetin alfa (Hospira)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Epoetin alfa (Hospira), covering 2018-07-19 to 2018-07-19. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin [Phase 3]